Duramesh combines implant incorporation in mesh repair with suture placement precision for the repair of soft tissues.

Mesh Suture, which does business as MSi, has secured 510(k) approval from the US Food and Drug Administration (FDA) for Duramesh, a non-absorbable polypropylene mesh suture for the surgical closure of soft tissues, including muscles, fascia, tendons and ligaments.

Duramesh is claimed to be a first-of-its-kind medical device, which uses the implant incorporation in mesh repair in combination with the placement precision of a suture to repair soft tissues.

The device is intended to reduce the problem of surgical failure resulting from suture pull-through.

Duramesh is claimed to be the world’s first and only mesh suture. Credit: MSi via BusinessWire.

A regular suture’s sharp leading edge can slice through intact tissue, which can lead to dehiscence, hernia formation and even poor tendon function. To resist pull-through, Duramesh’s architecture flattens right at the suture-tissue interface.

The open-walled hollow design of Duramesh also enables tissue ingrowth for implant incorporation without the formation of a capsule.

Duramesh was found to have fewer hernias and loose sutures numerically when compared to regular sutures in a porcine study.

Mesh Suture, which does business as MSi, has secured 510(k) approval from the US Food and Drug Administration (FDA) for Duramesh, a non-absorbable polypropylene mesh suture for the surgical closure of soft tissues, including muscles, fascia, tendons and ligaments.

Duramesh is claimed to be a first-of-its-kind medical device, which uses the implant incorporation in mesh repair in combination with the placement precision of a suture to repair soft tissues.

RELATED: Seer Medical receives FDA 510(k) for its at-home epilepsy diagnosis aide

The device is intended to reduce the problem of surgical failure resulting from suture pull-through.

A regular suture’s sharp leading edge can slice through intact tissue, which can lead to dehiscence, hernia formation and even poor tendon function. To resist pull-through, Duramesh’s architecture flattens right at the suture-tissue interface.

The open-walled hollow design of Duramesh also enables tissue ingrowth for implant incorporation without the formation of a capsule.

Duramesh was found to have fewer hernias and loose sutures numerically when compared to regular sutures in a porcine study.

Are you Hiring?